197 related articles for article (PubMed ID: 34174177)
21. Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.
Hudák A; Letoha A; Szilák L; Letoha T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069441
[TBL] [Abstract][Full Text] [Related]
22. Physiological implications of COVID-19 in reproduction: angiotensin-converting enzyme 2 a key player.
Sharma GT; Chandra V; Mankuzhy P; Thirupathi Y; Swain DK; Pillai H; Patel SK; Pathak M; Guttula S
Reprod Fertil Dev; 2021 Apr; 33(6):381-391. PubMed ID: 33731252
[TBL] [Abstract][Full Text] [Related]
23. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression.
Zlacká J; Stebelová K; Zeman M; Herichová I
Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351
[TBL] [Abstract][Full Text] [Related]
24. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.
Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH
J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323
[TBL] [Abstract][Full Text] [Related]
25. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).
Xiang Y; Wang M; Chen H; Chen L
Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003
[TBL] [Abstract][Full Text] [Related]
26. Meta-Analysis of APP Expression Modulated by SARS-CoV-2 Infection via the ACE2 Receptor.
Caradonna A; Patel T; Toleska M; Alabed S; Chang SL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163117
[TBL] [Abstract][Full Text] [Related]
27. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2.
Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I
J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
[TBL] [Abstract][Full Text] [Related]
29. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.
Ren W; Zhu Y; Lan J; Chen H; Wang Y; Shi H; Feng F; Chen DY; Close B; Zhao X; Wu J; Tian B; Yuan Z; Zhou D; Saeed M; Wang X; Zhang R; Ding Q
J Virol; 2022 Jan; 96(1):e0149221. PubMed ID: 34668773
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
[TBL] [Abstract][Full Text] [Related]
31. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802
[TBL] [Abstract][Full Text] [Related]
32. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
Huang K; Zhang Y; Hui X; Zhao Y; Gong W; Wang T; Zhang S; Yang Y; Deng F; Zhang Q; Chen X; Yang Y; Sun X; Chen H; Tao YJ; Zou Z; Jin M
EBioMedicine; 2021 May; 67():103381. PubMed ID: 33993052
[TBL] [Abstract][Full Text] [Related]
33. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
34. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.
Beyerstedt S; Casaro EB; Rangel ÉB
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):905-919. PubMed ID: 33389262
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 spike protein binding selectively accelerates substrate-specific catalytic activity of ACE2.
Kiseleva AA; Troisi EM; Hensley SE; Kohli RM; Epstein JA
J Biochem; 2021 Oct; 170(2):299-306. PubMed ID: 33774672
[TBL] [Abstract][Full Text] [Related]
36. Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity.
Mehrabadi ME; Hemmati R; Tashakor A; Homaei A; Yousefzadeh M; Hemati K; Hosseinkhani S
Biomed Pharmacother; 2021 May; 137():111363. PubMed ID: 33582450
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
[TBL] [Abstract][Full Text] [Related]
38. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
39. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
